Accounting for the emerging relevant role of AR-co-regulators in disease conditions spanning from cancer to neurodegeneration, we cannot rule out the possibility that diminished expression of two key AR co-regulators at least in part enhances mutant AR LOF, even if these co-regulators are overexpressed in skeletal muscle. Here, AR is linked to cancer.